Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study.
Lodato F, Azzaroli F, Brillanti S, Colecchia A, Tamé MR, Montagnani M, Muratori R, Giovanelli S, Feletti V, Bacchi Reggiani ML, Roda E, Mazzella G. Lodato F, et al. Among authors: brillanti s. J Viral Hepat. 2005 Sep;12(5):536-42. doi: 10.1111/j.1365-2893.2005.00638.x. J Viral Hepat. 2005. PMID: 16108771 Clinical Trial.
Severe acute autoimmune hepatitis after natalizumab treatment.
Lisotti A, Azzaroli F, Brillanti S, Mazzella G. Lisotti A, et al. Among authors: brillanti s. Dig Liver Dis. 2012 Apr;44(4):356-7. doi: 10.1016/j.dld.2011.11.003. Epub 2011 Dec 11. Dig Liver Dis. 2012. PMID: 22154948 No abstract available.
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older.
Conti F, Brillanti S, Buonfiglioli F, Vukotic R, Morelli MC, Lalanne C, Massari M, Foschi FG, Bernabucci V, Serio I, Prati GM, Negri E, Badia L, Caraceni P, Muratori P, Vitale G, Porro A, Morotti M, Mazzella G, Andreone P. Conti F, et al. Among authors: brillanti s. J Viral Hepat. 2017 Jun;24(6):454-463. doi: 10.1111/jvh.12663. Epub 2017 Feb 2. J Viral Hepat. 2017. PMID: 27976461
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes.
Carrai P, Morelli C, Cordone G, Romano A, Tamé M, Lionetti R, Pietrosi G, Lenci I, Piai G, Russo FP, Coppola C, Melazzini M, Montilla S, Pani L, Petraglia S, Russo P, Trotta MP, Martini S, Toniutto P; ITACOPS study group. Carrai P, et al. Transpl Int. 2017 Dec;30(12):1253-1265. doi: 10.1111/tri.13018. Epub 2017 Sep 7. Transpl Int. 2017. PMID: 28799277 Free article.
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals.
Ravaioli F, Conti F, Brillanti S, Andreone P, Mazzella G, Buonfiglioli F, Serio I, Verrucchi G, Bacchi Reggiani ML, Colli A, Marasco G, Colecchia A, Festi D. Ravaioli F, et al. Among authors: brillanti s. Dig Liver Dis. 2018 Jun;50(6):573-579. doi: 10.1016/j.dld.2018.02.010. Epub 2018 Feb 27. Dig Liver Dis. 2018. PMID: 29567413
45 results